Xconomy | Boston - Business + Technology in the Exponential Economy

ceo, Life Sciences, Inflammation

Lankau New CEO at Logical

Ryan McBride 5/11/09

Logical Therapeutics, a Waltham, MA-based developer of drugs to treat inflammation, says that Peter Lankau has been named CEO of the company, according to a press release. Lankau was previously CEO of Endo Pharmaceuticals (NASDAQ:ENDP), a specialty drug firm headquartered in Chadds Ford, PA. Rebecca caught up the Logical in late 2007 and detailed how Logical plans to develop a new compound that turns into anti-inflammation drug naproxen in the bloodstream.

Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com, or follow him on Twitter at http://twitter.com/Ryan_McBride.


Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.